I’ll Just Do A Round Up

I’m in no mood to write today. My headache is gone, but I got yet another reject email from yet another media organization I’d applied to and I am simply not in the mood to put too many sentences together.

The NY Times has an op-ed today arguing against lumping together Asperger’s syndrome and autism in the forthcoming DSM-5. It’s interesting that the paper would choose to highlight that issue since it’s been fairly quiet on developments around the new DSM. I wonder why.

The Chicago Tribune and ProPublica have a piece out on a Chicago psychiatrist who was prescribing tons of Clozaril to his patients (almost unheard of these days) as well as Seroquel. I was a source for the ProPublica reporter on this series (part two runs tomorrow and is allegedly “eye popping”) and it’s deeply ironic that the media organization that shot me down today is ProPublica. They don’t see a “fit” for me with them. Please. Go fuck yourselves, ProPublica.

Forest Labs and the feds have reached a tentative settlement over allegations that the drugmaker illegally marketed Lexapro and Celexa to kids and that it paid kickbacks to doctors. Is there a single maker of psychotropics who has not entered into a legal settlement with the feds in the last few years or who isn’t currently being investigated? Nope. That ought to tell you something.

Go to Source

Related posts:

  1. Lilly Settles Zyprexa Claims With South Carolina
  2. Psychiatrist Got $490,000 Pimping For Seroquel, Engaged In Wide Off-Label Use
  3. Lexapro Sales Stabilized By Lexapro Sales To Teens
  4. Lilly Settles Zyprexa Claims With Idaho
  5. Documents Show Lexapro Promoted By Tens Of Millions In Doctor Lunches, Lectures

Leave a Reply

Special Offers
Blogroll

Pages
Tags